Stock listing
NASDAQ:NRPH New River Pharmaceuticals Inc Stock
Follow New River Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:NRPH
$63.99 USD
Close on Apr 19, 2007 · No longer trades
- Lowest – highest close
- $3.19 – $63.99 USDSince Aug 5, 2004 · lowest Aug 13, 2004 · highest Apr 19, 2007
Delisted NASDAQ:NRPH no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:NRPH
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
New River Pharmaceuticals Inc on 6ix
- Decks
- 12 decks · latest Feb 6, 2007
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference 2007 | Conference | 8 slides | Feb 6, 2007 |
| Bear Stearns 19th Annual Investor Conference 2006 | Conference | 14 slides | Sep 12, 2006 |
| Technical Presentation (June 2006) | Technical | 46 slides | Jun 26, 2006 |
| Technical Presentation (June 2006) | Technical | 8 slides | Jun 20, 2006 |
| Technical Presentation (June 2006) | Technical | 19 slides | Jun 19, 2006 |
| Merrill Lynch Healthcare Conference 2006 | Conference | 10 slides | Feb 7, 2006 |
| First Albany Capital Annual Growth Conference 2005 | Conference | 21 slides | Dec 7, 2005 |
| Bear Stearns 18th Annual Investor Conference (September 2005) | Conference | 12 slides | Sep 12, 2005 |
| FBR Investor Conference 2005 | Conference | 18 slides | Jun 1, 2005 |
| UBS Global Pharmaceuticals Conference 2005 | Conference | 20 slides | May 23, 2005 |
All 12 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Wells Fargo Securities Healthcare Conference 2005 | Conference | 19 slides | Mar 1, 2005 |
| 17th Annual Bear Stearns Healthcare Conference 2004 | Conference | 23 slides | Sep 14, 2004 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Suma Krishnan Other companies: Krystal Biotech, Inc. (President, Research & Development · Since at least Sep 19, 2017); Precigen, Inc. (SVP--Product Development · Aug 7, 2013 – Jan 28, 2016 · Past) | Vice President, Product Dev. · Mar 29, 2005 – Jan 25, 2007 · Past |
| Garen Z Manvelian | Chief Medical Officer · Oct 4, 2006 – Oct 4, 2006 · Past |
| John K Thottathil | Chief Scientific Officer · Apr 17, 2006 – Apr 17, 2006 · Past |
| Robert D Colucci | Vice President, Clinical Devel · Jan 16, 2006 – Jan 17, 2006 · Past |
| Samir D Roy | VP Formulation & Manufacturing · Aug 16, 2006 – Aug 16, 2006 · Past |
Log in to ask 6ix AI your own questions about New River Pharmaceuticals Inc.